Literature DB >> 26583316

Deep clinical and neuropathological phenotyping of Pick disease.

David J Irwin1,2, Johannes Brettschneider3, Corey T McMillan1, Felicia Cooper1,2, Christopher Olm1, Steven E Arnold4, Vivianna M Van Deerlin2, William W Seeley5, Bruce L Miller5, Edward B Lee2,6, Virginia M-Y Lee2, Murray Grossman1, John Q Trojanowski2.   

Abstract

OBJECTIVE: To characterize sequential patterns of regional neuropathology and clinical symptoms in a well-characterized cohort of 21 patients with autopsy-confirmed Pick disease.
METHODS: Detailed neuropathological examination using 70μm and traditional 6μm sections was performed using thioflavin-S staining and immunohistochemistry for phosphorylated tau, 3R and 4R tau isoforms, ubiquitin, and C-terminally truncated tau. Patterns of regional tau deposition were correlated with clinical data. In a subset of cases (n = 5), converging evidence was obtained using antemortem neuroimaging measures of gray and white matter integrity.
RESULTS: Four sequential patterns of pathological tau deposition were identified starting in frontotemporal limbic/paralimbic and neocortical regions (phase I). Sequential involvement was seen in subcortical structures, including basal ganglia, locus coeruleus, and raphe nuclei (phase II), followed by primary motor cortex and precerebellar nuclei (phase III) and finally visual cortex in the most severe (phase IV) cases. Behavioral variant frontotemporal dementia was the predominant clinical phenotype (18 of 21), but all patients eventually developed a social comportment disorder. Pathological tau phases reflected the evolution of clinical symptoms and degeneration on serial antemortem neuroimaging, directly correlated with disease duration and inversely correlated with brain weight at autopsy. The majority of neuronal and glial tau inclusions were 3R tau-positive and 4R tau-negative in sporadic cases. There was a relative abundance of mature tau pathology markers in frontotemporal limbic/paralimbic regions compared to neocortical regions.
INTERPRETATION: Pick disease tau neuropathology may originate in limbic/paralimbic cortices. The patterns of tau pathology observed here provide novel insights into the natural history and biology of tau-mediated neurodegeneration.
© 2015 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26583316      PMCID: PMC4755803          DOI: 10.1002/ana.24559

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  48 in total

Review 1.  Pick complex--historical introduction.

Authors:  Andrew Kertesz
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

2.  Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template.

Authors:  Susumu Mori; Kenichi Oishi; Hangyi Jiang; Li Jiang; Xin Li; Kazi Akhter; Kegang Hua; Andreia V Faria; Asif Mahmood; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter van Zijl; John Mazziotta
Journal:  Neuroimage       Date:  2008-01-03       Impact factor: 6.556

3.  Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.

Authors:  Osamu Yokota; Kuniaki Tsuchiya; Tetsuaki Arai; Saburo Yagishita; Osamu Matsubara; Akihide Mochizuki; Akira Tamaoka; Mitsuru Kawamura; Hidetoshi Yoshida; Seishi Terada; Hideki Ishizu; Shigetoshi Kuroda; Haruhiko Akiyama
Journal:  Acta Neuropathol       Date:  2009-02-05       Impact factor: 17.088

4.  Neuropathology of Pick body disease.

Authors:  Toshiki Uchihara; Kuniaki Tsuchiya
Journal:  Handb Clin Neurol       Date:  2008

5.  Early frontotemporal dementia targets neurons unique to apes and humans.

Authors:  William W Seeley; Danielle A Carlin; John M Allman; Marcelo N Macedo; Clarissa Bush; Bruce L Miller; Stephen J Dearmond
Journal:  Ann Neurol       Date:  2006-12       Impact factor: 10.422

6.  Phosphorylation and cleavage of tau in non-AD tauopathies.

Authors:  Angela L Guillozet-Bongaarts; Kelly E Glajch; Emilie G Libson; Michael E Cahill; Eileen Bigio; Robert W Berry; Lester I Binder
Journal:  Acta Neuropathol       Date:  2007-03-15       Impact factor: 17.088

7.  Biochemical and pathological characterization of frontotemporal dementia due to a Leu266Val mutation in microtubule-associated protein tau in an African American individual.

Authors:  Vivianna M Van Deerlin; Mark S Forman; Jennifer M Farmer; Murray Grossman; Sonali Joyce; Alex Crowe; John Q Trojanowski; Virginia M-Y Lee; Anjan Chatterjee
Journal:  Acta Neuropathol       Date:  2006-10-28       Impact factor: 17.088

8.  Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia.

Authors:  William W Seeley; Richard Crawford; Katya Rascovsky; Joel H Kramer; Michael Weiner; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Arch Neurol       Date:  2008-02

9.  Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia.

Authors:  Jennifer L Whitwell; Keith A Josephs; Martin N Rossor; John M Stevens; Tamas Revesz; Janice L Holton; Safa Al-Sarraj; Alison K Godbolt; Nick C Fox; Jason D Warren
Journal:  Arch Neurol       Date:  2005-09

10.  Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2009-11-19       Impact factor: 17.088

View more
  72 in total

1.  Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.

Authors:  David J Irwin; Alberto Lleó; Sharon X Xie; Corey T McMillan; David A Wolk; Edward B Lee; Viviana M Van Deerlin; Leslie M Shaw; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2017-08-19       Impact factor: 10.422

2.  Tauopathy with hippocampal 4-repeat tau immunoreactive spherical inclusions: a report of three cases.

Authors:  Gabor G Kovacs; Linda K Kwong; Murray Grossman; David J Irwin; Edward B Lee; John L Robinson; Eunran Suh; Vivianna M Van Deerlin; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-01-19       Impact factor: 6.508

Review 3.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

4.  Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.

Authors:  Emilia M Gatto; Ricardo F Allegri; Gustavo Da Prat; Patricio Chrem Mendez; David S Hanna; Michael O Dorschner; Ezequiel I Surace; Cyrus P Zabetian; Ignacio F Mata
Journal:  Neurobiol Aging       Date:  2017-02-10       Impact factor: 4.673

5.  [18F]-AV-1451 tau PET imaging in Alzheimer's disease and suspected non-AD tauopathies using a late acquisition time window.

Authors:  Julien Lagarde; Pauline Olivieri; Fabien Caillé; Philippe Gervais; Jean-Claude Baron; Michel Bottlaender; Marie Sarazin
Journal:  J Neurol       Date:  2019-09-18       Impact factor: 4.849

6.  Evaluating the Patterns of Aging-Related Tau Astrogliopathy Unravels Novel Insights Into Brain Aging and Neurodegenerative Diseases.

Authors:  Gabor G Kovacs; John L Robinson; Sharon X Xie; Edward B Lee; Murray Grossman; David A Wolk; David J Irwin; Dan Weintraub; Christopher F Kim; Theresa Schuck; Ahmed Yousef; Stephanie T Wagner; Eunran Suh; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  2017-04-01       Impact factor: 3.685

7.  Asymmetry of post-mortem neuropathology in behavioural-variant frontotemporal dementia.

Authors:  David J Irwin; Corey T McMillan; Sharon X Xie; Katya Rascovsky; Vivianna M Van Deerlin; H Branch Coslett; Roy Hamilton; Geoffrey K Aguirre; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Murray Grossman
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

8.  Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia.

Authors:  Lucia A A Giannini; Sharon X Xie; Corey T McMillan; Mendy Liang; Andrew Williams; Charles Jester; Katya Rascovsky; David A Wolk; Sharon Ash; Edward B Lee; John Q Trojanowski; Murray Grossman; David J Irwin
Journal:  Ann Neurol       Date:  2019-03-28       Impact factor: 10.422

Review 9.  Emerging Diagnostic and Therapeutic Strategies for Tauopathies.

Authors:  David Coughlin; David J Irwin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

10.  A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.

Authors:  Alberto Lleó; David J Irwin; Ignacio Illán-Gala; Corey T McMillan; David A Wolk; Edward B Lee; Vivianna M Van Deerlin; Leslie M Shaw; John Q Trojanowski; Murray Grossman
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.